City: São Paulo
See other companies with research projects supported by PIPE ProgramHuman papillomavirus (HPV) is the etiological agent of the most common sexually transmitted infection. Most infections are asymptomatic and are usually eliminated by the immune system, without any intervention. However, persistent HPV infections can lead to cervical intraepithelial neoplasia (CINs) and uterine cervix cancer, in addition to other types of cancer such as oropharyngeal and p…
Cervical cancer induced by HPV is a serious public health problem and represents the fourth most common type of cancer in women. Patients diagnosed with this type of cancer are treated with surgery, radio and/or chemotherapy. More recently, immunotherapies based on monoclonal antibodies were incorporated into the treatment of cervical cancer in an attempt to increase patient survival. How…
Dengue virus (DENV) and Zika virus (ZIKV) infections are extremely important for public health, being endemic in 141 countries. Although most signs and symptoms of the disease are mild and self-limiting, it is known that grave infections by DENV and ZIKV can lead to complications. According to data from the Pan American Health Organization, all four DENV serotypes lead to approximately 5…
he emergence of betacoronavirus SARS-CoV-2 at the end of 2019 in China lasts for almost a year and has already resulted in more than 30 million infections and 1 million deaths worldwide. Vaccines are essential and urgently needed to control the pandemic and the strategies under development are mostly aimed at inducing antibodies against the viral protein spike, responsible for binding to …
Human papillomavirus (HPV) infection is considered the most common sexually transmitted disease and eight out of ten people have ever come into contact with it at some point in their lives. Most HPV infections are asymptomatic and are controlled by the immune system without intervention. However, persistent infections caused by this virus can lead to the onset of both uterine cervix lesio…
The difficulty in developing new biopharmaceuticals in Brazil led researchers from USP to found a company to enable the progress of an immunotherapeutic strategy against HPV-induced tumors. The company aims the optimization of the formulation, the conduction of clinical trials and later, the product commercialization. The immunotherapy in question, created in the Vaccine Development Labor…
| 3 / 3 | Ongoing research grants |
| 3 / 3 | Completed research grants |
| 6 / 6 | All Research Grants |
| Associated processes | |
Carregando Filtros. Aguarde...
Left-click and hold. Drag the cursor on the map until you see the view you want.
Select year: |
Show years by sequential order |